Debt to Equity Ratio Chart

View Debt to Equity Ratio for RBSH.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Debt to Equity Ratio Chart
Start Trial

Historical Debt to Equity Ratio Data

View and export this data back to 2008. Start Trial.
Date Value
June 30, 2023 -0.0553
March 31, 2023 -0.0548
December 31, 2022 -0.0592
September 30, 2022 -0.0527
June 30, 2022 -0.05
March 31, 2022 -0.0597
December 31, 2021 -0.1023
September 30, 2021 -0.0827
June 30, 2021 -0.0361
March 31, 2021 -0.0122
December 31, 2020 -0.1502
September 30, 2020 -0.2971
June 30, 2020 -0.2633
March 31, 2020 -0.2854
December 31, 2019 -0.324
September 30, 2019 -0.3357
June 30, 2019 -0.3023
March 31, 2019 -0.3165
December 31, 2018 -0.3145
September 30, 2018 -0.2508
June 30, 2018 -0.3109
March 31, 2018 -0.2808
December 31, 2017 -0.2798
September 30, 2017 -0.4109
June 30, 2017 0.00
Date Value
March 31, 2017 0.00
December 31, 2016 0.00
September 30, 2016 0.00
June 30, 2016 0.00
March 31, 2016 0.00
December 31, 2015 0.00
September 30, 2015 -0.0571
June 30, 2015 -0.0372
March 31, 2015 -0.0778
December 31, 2014 1.082
September 30, 2014 0.0797
June 30, 2014 0.0371
March 31, 2014 0.1688
December 31, 2013 0.0833
September 30, 2013 0.0322
June 30, 2013 -0.2313
March 31, 2013 0.3671
December 31, 2012 -0.1442
September 30, 2012 -0.1886
June 30, 2012 0.1084
March 31, 2012 0.0641
December 31, 2011 0.0344
September 30, 2011 0.0236
June 30, 2011 0.019
March 31, 2011 0.0219

Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

View Debt to Equity Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Debt to Equity Ratio Benchmarks

View Debt to Equity Ratio Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. 0.0565
Alnylam Pharmaceuticals, Inc. 2.206
Anika Therapeutics, Inc. 0.1839
Savara, Inc. 0.2117
Vericel Corp. 0.2556